Opioids Market to 2017 - Steady Uptake of Oxycontin and High Incidence Of Diseases Such As Cancer And Arthritis to Drive the Market - GBI Research Reports

Opioids Market to 2017 - Steady Uptake of Oxycontin and High Incidence Of Diseases Such As Cancer And Arthritis to Drive the Market

Opioids Market to 2017 - Steady Uptake of Oxycontin and High Incidence Of Diseases Such As Cancer And Arthritis to Drive the Market - GBI Research Reports
Opioids Market to 2017 - Steady Uptake of Oxycontin and High Incidence Of Diseases Such As Cancer And Arthritis to Drive the Market
Published Jun 01, 2011
177 pages — Published Jun 01, 2011
Price US$ 3,500.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

GBI Research, the leading business intelligence provider, has released its latest research, Opioids Market to 2017 - Steady Uptake of Oxycontin and High Incidence Of Diseases Such As Cancer And Arthritis to Drive the Market, which provides insights into global opioids market and market forecast until 2017. The report provides an in-depth analysis of the top seven therapeutic indications for which often opioids are prescribed which includes fibromyalgia, neuropathic pain, cancer pain, osteoarthritis pain, rheumatoid arthritis pain, low back pain and post operative pain. The report also examines the global opioids treatment usage patterns for the covered indication. In addition, the report also includes insights into the opioids R&D pipeline.

Report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Researchs team of industry experts.

GBI Research analysis shows that the overall global opioids market for the seven indications fibromyalgia, neuropathic pain, cancer pain, osteoarthritis pain, rheumatoid arthritis pain, low back pain and post operative pain was valued at $11.2 billion in 2010. The market is expected to witness a CAGR of 2.8% for the forecast period. Patent expiries of leading opioids followed by generic erosions along with adverse effects associated with use of opioids are the main reasons for marginal growth in opioids market. However expected launch of new opioids is expected to push the market in future.

The US was the largest region for the opioids market in terms of revenue, accounting for 49% followed by top five countries in Europe and Japan which contributed 36% and 15% respectively.

The top pharmaceutical companies in opioids market are Johnson & Johnson, Cephalon and several mid size players such as Purdue Pharma, King Pharmaceuticals, Orexo and Endo Pharmaceuticals. Large amount of fragmentation in the market provides significant scope for consolidation through mergers and acquisitions.

Scope

The scope of this report includes -
- Data and analysis on the global opioids market.
- Annualized market data for the opioids market from 2002 to 2010, with forecasts to 2017.
- Market data on the therapeutic landscape which covers fibromyalgia, neuropathic pain, cancer pain, osteoarthritis pain, rheumatoid arthritis pain, low back pain and post operative pain therapeutics including market size, market share, annual cost of therapy, sales volume and treatment usage patterns such as disease population and treated population.
- Key drivers and restraints that have had a significant impact on the market and on each indication.
- The competitive landscape of the global opioids market which includes companies such as Johnson & Johnson, Cephalon, Purdue Pharma, King Pharmaceuticals, Orexo and Endo Pharmaceuticals.
- Key M&A activities and Licensing Agreements that took place from 2005 to 2010 in the global opioids market.

Reasons to buy

The report will enhance your decision making capability. It will allow you to -
- Align your product portfolio to the markets with high growth potential.
- Develop market-entry and market expansion strategies by identifying the potential region and therapeutic segments poised for strong growth.
- Device a more tailored country strategy through the understanding of key drivers and barriers of the regions opioids market.
- Develop key strategic initiatives by understanding the key focus areas and top selling opioids molecules of leading companies.
- Accelerate and strengthen your market position by identifying key companies for mergers, acquisitions and strategic partnerships.

  
Source:
Document ID
GBIHC091MR
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents38
  List of Tables62
  List of Figures83
Opioids Market to 2017: Introduction112
  GBI Research Report Guidance112
Opioids Market: Market Overview1329
  Introduction131
  Opioids: A Classification132
    Branded Generics Play a Major Role151
    Novel Drug Delivery Techniques Push Opioid Usage151
  Adverse Effects Associated With Opioids Restrain Its Prescription161
  REMS171
    What are REMS?171
    Implications of REMS181
    REMS for Opioids191
  Revenue201
  Major Marketed Opioids211
    Oxycontin211
      Overview211
      Mechanism of Action211
      Efficacy Details211
      Safety Issues221
    Embeda221
      Overview221
      Mechanism of Action221
      Efficacy221
      Safety Issues221
    Exalgo231
      Overview231
      Mechanism of Action231
      Efficacy231
      Safety Issues231
    Onsolis241
      Overview241
      Mechanism of Action241
      Efficacy241
      Safety Issues251
    Avinza251
      Overview251
      Mechanism of Action251
      Efficacy Details251
      Safety Issues251
      Life Cycle Management261
    Duragesic261
      Overview261
      Mechanism of Action261
      Safety Issues261
    Kadian271
      Overview271
      Mechanism of Action271
      Safety Issues271
    Opana ER271
      Overview271
      Mechanism of Action271
      Efficacy281
      Safety Issues281
    Vicodin CR281
      Overview281
      Mechanism of Action281
      Safety Issues291
    Dolophine291
      Overview291
      Mechanism of Action291
      Safety Issues291
    MS Contin301
      Overview301
      Mechanism of Action301
      Safety Issues301
    Oramorph301
      Overview301
      Mechanism of Action301
      Safety Issues312
  FDA Regulations Regarding Opioids331
    FDA Regulations on Opioid Combinations with Acetaminophen331
    Darvocet, Darvon (Propoxyphene) Withdrawn From the Market331
  Annual Cost of Therapy331
  Treatment Usage Patterns342
    Diseased Population361
    Treatment Seeking Population371
    Diagnosed Population381
    Prescription Population391
  Drivers and Restraints of the Opioids Market401
    Drivers401
      Rising Elderly Populations401
      Implementation of REMS will Reduce Safety Issues401
      Rise in Incidence of Indications Such as Cancer and Arthritis401
    Restraints411
      Opioid Usage is Associated with Several Adverse Affects411
      Addiction and Tolerance411
      Diversion411
      Weak pipeline411
Opioids Market: Therapeutic Landscape4279
  Opioids Market for Fibromyalgia421
    Introduction421
    Revenue and Forecasts422
    Annual Cost of Therapy441
    Treatment Usage Patterns451
      Diseased Population461
      Treatment Seeking Population471
      Diagnosed Population481
      Prescription Population491
    Geographical Segmentation502
  Drivers and Restraints for the Opioids Market for Fibromyalgia521
    Drivers521
      Elderly Populations Will Drive Prevalence521
      Improvements in Awareness and Resultant Diagnosis Levels Will Drive the Market521
      Substantial Unmet Need Increases the Market Potential521
    Restraints531
      Limitations in the Efficacy of Existing Drugs Leads Can Potentially Lead to Low Prescription531
      Inadequate Knowledge of Disease Progression Hinders the Development of Drugs With Better Efficacy531
  Opioids for Neuropathic Pain541
    Introduction541
    Revenue and Forecasts541
    Annual Cost of Therapy551
    Treatment Usage Patterns561
      Antidepresssants561
      Anticonvulsants571
      Diseased Population581
      Treatment Seeking Population591
      Diagnosed Population601
      Prescription Population611
    Geographical Segmentation622
  Drivers and Restraints for the Opioids Market for Neuropathic Pain641
    Drivers641
      Ageing Population and Increasing Prevalence of Diabetes and HIV641
      More Active Treatment Seeking Behavior to Drive Increase in Patient Volumes641
    Restraints641
      Non-availability of Accurate Tools that Aid Diagnosis is a Hindrance for Market Growth641
      Neuropathic pain, which is a chronic pain indication, does not respond well to opioids.651
  Opioids Market for Cancer Pain651
    Introduction651
      The Cancer Pain Drug Market is Fuelled by Opioids661
    Revenue and Forecasts661
    Annual Cost of Therapy671
    Treatment Usage Patterns682
      Diseased Population701
      Treatment Seeking Population711
      Diagnosed Population721
      Prescription Population731
    Geographical Segmentation742
    Drivers and Restraints for the Opioids Market for Cancer Pain761
    Drivers761
      Rising Incidence of Cancer Drives the Market761
      New Modes of Delivery Will Help in Better Management of the Pain for a Longer Duration761
    Restraints771
      Concerns Over the Risks of Addiction Related to Drug Therapy Affect the Prescription Rate771
      Patients Fear That Treatment for Pain will Interfere in Their Cancer Treatment771
  Opioids Market for Osteoarthritis Pain771
    Introduction771
    Revenue and Forecasts781
    Annual Cost of Therapy791
    Treatment Usage Patterns801
      Diseased Population811
      Treatment Seeking Population821
      Diagnosed Population831
      Prescription Population841
    Geographical Segmentation852
    Drivers and Restraints for the Opioids Market for Osteoarthritis Pain871
    Drivers871
      Aging population871
      Rapid Increase of the Obesity Population871
      Lifestyle Changes Increase Incidence of Osteoarthritis871
    Restraints881
      Opioids Are Associated With Several Side Effects881
  Opioids Market for Rheumatoid Arthritis Pain881
    Introduction881
    Revenue and Forecasts881
    Annual Cost of Therapy892
    Treatment Usage Patterns911
      Diseased Population921
      Treatment Seeking Population931
      Diagnosed Population941
      Prescription Population951
    Geographical Segmentation962
    Drivers and Restraints for Opioids Market for Rheumatoid Arthritis Pain981
    Drivers981
      Increasing Incidence and Treatment seeking rate981
    Restrains981
      Inadequate Awareness of Pain Management981
      Adverse Effects981
  Opioids Market for Low Back Pain991
    Introduction991
    Revenue and Forecasts991
    Annual Cost of Therapy1001
    Treatment Usage Patterns1011
      Diseased Population1021
      Treatment Seeking Population1031
      Diagnosed Population1041
      Prescription Population1051
    Geographical Segmentation1062
    Drivers and Restraints for the Opioids Market for Low Back Pain1081
    Drivers1081
      Rising Elderly Population Will Drive the Market1081
      Sedentary Lifestyle increases LBP1081
    Restraints1081
      Low Treatment Seeking Rate and Low Prescription Rate Restricts the Market1081
  Opioids Market for Post-operative Pain1091
    Introduction1091
    Revenue and Forecasts1091
    Annual Cost of Therapy1101
    Treatment Usage Patterns1112
      Diseased Population1131
      Treatment Seeking Population1141
      Diagnosed Population1151
      Prescription Population1161
    Geographical Segmentation1172
    Drivers and Restraints for the Opioids Market for Post-operative Pain1191
    Drivers1191
      Substantial Unmet Need Increases Market Potential1191
      Titration of Opioids is Convenient in a Surgical Facility1191
    Restraints1191
      Expansion of Minimally Invasive Surgical Procedures1191
      Peri-operative Side Effects1191
  Opioids Market for Other Indications1201
    Introduction1201
    Revenue1201
Opioids Market: Geographical Landscape12125
  The US1231
    Revenue and Forecasts1232
    Annual Cost of Therapy1251
    Treatment Usage Patterns1262
      Diseased Population1281
      Treatment Seeking Population1291
      Diagnosed Population1301
      Prescription Population1311
  Top Five Countries in Europe1321
    Revenue and Forecasts1321
    Annual Cost of Therapy1331
    Treatment Usage Patterns1341
      Diseased Population1351
      Treatment Seeking Population1361
      Diagnosed Population1371
      Prescription Population1381
  Japan1391
    Revenue and Forecasts1391
    Annual Cost of Therapy1401
    Treatment Usage Patterns1411
      Diseased Population1421
      Treatment Seeking Population1431
      Diagnosed Population1441
      Prescription Population1451
Opioids Market: Pipeline Analysis1466
  Introduction1462
    Research and Development Pipeline Neuropathic Pain1481
    Research and Development Pipeline Cancer Pain1491
  Profiles of Key Late-Stage Drugs in the Opioids Market1491
    Fentanyl TAIFUN - AKELA Pharma Inc.1491
      Mechanism of Action1491
    Fentanyl Sublingual Spray - INSYS Therapeutics, Inc.1501
    Oxycodone hydrochloride - Mundipharma International Limited1501

Table Of Contents

GBI Research Reports—GBI Research covers worldwide markets and issues, supplies actionable data and forecasts and is driven by industry leaders' insights. GBI Research provides a broad spectrum of reports across the healthcare and energy industries and its online offering is easy to navigate - a comprehensive resource for business information needs.

About the Author


Cite this Report

  
MLA:
GBI Research Reports. "Opioids Market to 2017 - Steady Uptake of Oxycontin and High Incidence Of Diseases Such As Cancer And Arthritis to Drive the Market" Jun 01, 2011. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GBI-Research-Reports/Opioids-Market-to-2017-Steady-Uptake-of-Oxycontin-and-High-Incidence-Of-Diseases-Such-As-Cancer-And-Arthritis-to-Drive-the-Market-2115-219>
  
APA:
GBI Research Reports. (2011). Opioids Market to 2017 - Steady Uptake of Oxycontin and High Incidence Of Diseases Such As Cancer And Arthritis to Drive the Market Jun 01, 2011. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GBI-Research-Reports/Opioids-Market-to-2017-Steady-Uptake-of-Oxycontin-and-High-Incidence-Of-Diseases-Such-As-Cancer-And-Arthritis-to-Drive-the-Market-2115-219>
  
US$ 3,500.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.